Abstract
The concentration-dependent effects of a series of lipoxygenase inhibitors and antioxidants on the macrophage-mediated oxidative modification of low-density lipoprotein (LDL) were measured. Their influence on macrophage 5-lipoxygenase pathway activity was also studied over the same concentration range. No correlation between inhibition of 5-lipoxygenase and of macrophage-mediated oxidation of LDL was observed. The capacity of the compounds to prevent cell-mediated modification of LDL could be explained in terms of their activity as either aqueous- or lipid-peroxyl radical scavengers. Two potent 5-lipoxygenase inhibitors (MK 886 and Revlon 5901), which had no radical-scavenging properties, were unable to block LDL modification. It is concluded that 5-lipoxygenase is not essential for LDL oxidation by macrophages.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine / pharmacology
-
5,8,11,14-Eicosatetraynoic Acid / pharmacology
-
Animals
-
Antioxidants / pharmacology
-
Arachidonate 5-Lipoxygenase / metabolism*
-
Benzeneacetamides*
-
Butylated Hydroxytoluene / pharmacology
-
Cells, Cultured
-
Endocytosis / drug effects
-
Free Radical Scavengers
-
Humans
-
Hydroxamic Acids / pharmacology
-
Indoles / pharmacology
-
Lipoproteins, LDL / metabolism*
-
Lipoxygenase Inhibitors
-
Macrophages / metabolism*
-
Masoprocol / pharmacology
-
Mice
-
Oxidation-Reduction
Substances
-
Antioxidants
-
Benzeneacetamides
-
Free Radical Scavengers
-
Hydroxamic Acids
-
Indoles
-
Lipoproteins, LDL
-
Lipoxygenase Inhibitors
-
MK-886
-
N-(3-phenoxycinnamyl)acetohydroxamic acid
-
5,8,11,14-Eicosatetraynoic Acid
-
Butylated Hydroxytoluene
-
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine
-
Masoprocol
-
Arachidonate 5-Lipoxygenase